Ralf Zahn

Showing 1-14 of 14 articles

Everolimus-eluting bioresorbable scaffolds in patients with coronary artery disease: results from the German-Austrian ABSORB RegIstRy (GABI-R)

Nef H, Wiebe J, Kastner J, Mehilli J, Münzel T, Naber C, Neumann T, Richardt G, Schmermund A, Wöhrle J, Zahn R, Riemer T, Achenbach S, Hamm C

December 20, 2017 | 10.4244/EIJ-D-17-00330

Clinical restenosis and its predictors after implantation of everolimus-eluting bioresorbable vascular scaffolds: results from GABI-R

Mehilli J, Achenbach S, Wöhrle J, Baquet M, Riemer T, Münzel T, Nef H, Naber C, Richardt G, Zahn R, Gori T, Neumann T, Kastner J, Schmermund A, Hamm C, Wöhrle J, Richardt G

December 20, 2017 | 10.4244/EIJ-D-17-00291

Interventions for valvular disease

How should I treat recurrent severe paravalvular leakage after successful interventional closure of a symptomatic paravalvular leak with four plug devices following complicated bioprosthetic aortic valve replacement? The importance of closely monitoring patients after interventional procedures

Werner N, Kilkowski C, Fraiture B, Zeymer U, Zahn R, Gafoor S, Butera G

September 20, 2017 | 10.4244/EIJ-D-15-00001

Interventions for valvular disease

Left ventricular function determines the survival benefit for women over men after transcatheter aortic valve implantation (TAVI)

Bauer T, Möllmann H, Beckmann A, Ensminger S, Frerker C, Holzhey D, Berkowitsch A, Zahn R, Mohr F, Hamm C, Walther T

July 20, 2017 | 10.4244/EIJ-D-16-00622

Interventions for stroke

The shrinking carotid stent

Keranov S, Zahn R, Zeymer U

June 20, 2016 | 10.4244/EIJV12I3A67

Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry

Zeymer U, Hochadel M, Thiele H, Andresen D, Schühlen H, Brachmann J, Elsasser A, Gitt A, Zahn R

July 20, 2015 | 10.4244/EIJY14M08_04

TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY)

Lauten A, Figulla HR, Möllmann H, Holzhey D, Kotting J, Beckmann A, Veit C, Cremer J, Kuck K, Lange R, Zahn R, Sack S, Schuler G, Walther T, Beyersdorf F, Böhm M, Heusch G, Meinertz T, Neumann T, Welz A, Mohr F, Hamm C

November 20, 2014 | 10.4244/EIJV10I7A145

Transcatheter aortic valve implantation (TAVI) by centres with and without an on-site cardiac surgery programme: preliminary experience from the German TAVI registry

Eggebrecht H, Mehta R, Haude M, Sack S, Mudra H, Hein R, Brachmann J, Gerckens U, Kuck K, Zahn R, Sechtem U, Richardt G, Schneider S, Senges J

September 28, 2014 | 10.4244/EIJV10I5A105

A plea for caution: transcatheter aortic valve implantation using the Medtronic CoreValve™ prosthesis without balloon predilatation

Zahn R, Bauer T, Sack F-U, Lehman A, Cornelius B, Schiele R

September 27, 2013 | 10.4244/EIJV9I5A105

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery

Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H

August 23, 2013 | 10.4244/EIJV9I4A73

Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry

Rittger H, Hochadel M, Behrens S, Hauptmann K-E, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U

February 21, 2012 | 10.4244/EIJV7I10A191

Use and impact of intra-aortic balloon pump on mortality in patients with acute myocardial infarction complicated by cardiogenic shock: results of the Euro Heart Survey on PCI

Zeymer U, Bauer T, Hamm C, Zahn R, Weidinger F, Seabra-Gomes R, Hochadel M, Marco J, Gitt A

August 30, 2011 | 10.4244/EIJV7I4A72

Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006

Werner G, Hochadel M, Zeymer U, Kerber S, Schumacher B, Grube E, Hauptmann K-E, Brueck M, Zahn R, Senges J

August 15, 2010

Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Zeymer U, Gitt A, Zahn R, Jünger C, Bauer T, Heer T, Koeth O, Senges J

January 20, 2009

1

Latest news

EAPCI/ACVC consensus on pVADs, coronary physiology mini focus, a new analysis from the COAPT trial, patient selection for tricuspid interventions and more…

Treatment of secondary mitral regurgitation in patients with heart failure

Marco Metra et al

This Week's JAA's: Principles and Pitfalls in CFT, Brachial access for PCI....

Coronary flow capacity: where to next?

Nils P. Johnson

Joint EAPCI/ACVC expert consensus document on pVADs

EuroIntervention's new impact factor!

STATE OF THE ART

Completeness of Revascularisation in ACS Patients with Multivessel Disease

Valeria Paradies et al.

Valvular disease